VRNA vs. INSM

Last updated Apr 1, 2026

Compare and contrast key facts about Verona Pharma plc (VRNA) and Insmed Incorporated (INSM).

Performance

VRNA vs. INSM - Performance Comparison

The chart below illustrates the hypothetical performance of a $10,000 investment in Verona Pharma plc (VRNA) and Insmed Incorporated (INSM). The values are adjusted to include any dividend payments, if applicable.

VRNA vs. INSM - Yearly Performance Comparison

	2026 (YTD)	2025	2024	2023	2022	2021	2020	2019	2018	2017
VRNA Verona Pharma plc	0.00%	130.21%	133.60%	-23.92%	288.84%	-4.00%	21.74%	-40.41%	-18.71%	-12.07%
INSM Insmed Incorporated	-6.04%	152.09%	122.78%	55.11%	-26.65%	-18.17%	39.41%	82.01%	-57.92%	66.12%

Fundamentals

Market Cap VRNA : $9.72B INSM : $34.93B
EPS VRNA : -$0.69 INSM : -$6.23
PS Ratio VRNA : 57.97 INSM : 55.22
PB Ratio VRNA : 34.92 INSM : 47.27
Total Revenue (TTM) VRNA : $167.65M INSM : $606.42M
Gross Profit (TTM) VRNA : $159.52M INSM : $483.49M
EBITDA (TTM) VRNA : -$40.86M INSM : -$1.19B

Returns By Period

VRNA

• 1D: —
• 1M: —
• YTD: —
• 6M: —
• 1Y: —
• 3Y*: —
• 5Y*: —
• 10Y*: —

INSM

• 1D: 6.65%
• 1M: 9.50%
• YTD: -6.04%
• 6M: 13.55%
• 1Y: 114.34%
• 3Y*: 112.46%
• 5Y*: 35.77%
• 10Y*: 29.16%

*Multi-year figures are annualized to reflect compound growth (CAGR)

Return for Risk

VRNA vs. INSM — Risk / Return Rank

Compare risk-adjusted metric ranks to identify better-performing investments over the past 12 months.

INSM

INSM Risk / Return Rank: 89
INSM Sharpe Ratio Rank: 92
INSM Sortino Ratio Rank: 92
INSM Omega Ratio Rank: 92
INSM Calmar Ratio Rank: 87
INSM Martin Ratio Rank: 84

The rank (0–100) shows how this investment's returns compare to the risk taken. Higher = better. Based on the past 12 months of data, combining Sharpe, Sortino, and other metrics used by quantitative funds and institutional investors.

VRNA vs. INSM - Risk-Adjusted Trends Comparison

This table presents a comparison of risk-adjusted performance metrics for Verona Pharma plc (VRNA) and Insmed Incorporated (INSM). Risk-adjusted metrics are performance indicators that assess an investment's returns in relation to its risk, enabling a more accurate comparison of different investment options.

Risk / return metrics aren't available yet — we need at least 12 months of trading data to calculate them.

Sharpe Ratios by Period

	VRNA	INSM	Difference
Sharpe Ratio (1Y) Calculated over the trailing 1-year period	—	2.16	—
Sharpe Ratio (5Y) Calculated over the trailing 5-year period	—	0.50	—
Sharpe Ratio (10Y) Calculated over the trailing 10-year period	—	0.37	—
Sharpe Ratio (All Time) Calculated using the full available price history	—	-0.00	—

Correlation

The correlation between VRNA and INSM is 0.19, which is considered to be low. This implies their price changes are not closely related. A low correlation is generally favorable for portfolio diversification, as it helps to reduce overall risk by spreading it across multiple assets with different performance patterns.

Dividends

VRNA vs. INSM - Dividend Comparison

Neither VRNA nor INSM has paid dividends to shareholders.

Tickers have no history of dividend payments

Drawdowns

Drawdown Indicators

	VRNA	INSM	Difference
Max Drawdown Largest peak-to-trough decline	—	-98.65%	—
Max Drawdown (1Y) Largest decline over 1 year	—	-35.67%	—
Max Drawdown (5Y) Largest decline over 5 years	—	-54.85%	—
Max Drawdown (10Y) Largest decline over 10 years	—	-64.84%	—
Current Drawdown Current decline from peak	—	-22.65%	—
Average Drawdown Average peak-to-trough decline	—	-86.44%	—
Ulcer Index Depth and duration of drawdowns from previous peaks	—	14.84%	—

Volatility

Volatility by Period

	VRNA	INSM	Difference
Volatility (1M) Calculated over the trailing 1-month period	—	15.95%	—
Volatility (6M) Calculated over the trailing 6-month period	—	35.51%	—
Volatility (1Y) Calculated over the trailing 1-year period	—	53.23%	—
Volatility (5Y) Calculated over the trailing 5-year period, annualized	—	72.40%	—
Volatility (10Y) Calculated over the trailing 10-year period, annualized	—	78.16%	—

Financials